Table 2.

Pearson correlations for the combined groups of circulating androgen levels after DHEA or placebo administration vs. change from baseline (%) in the fasting state of inflammation markers that signifies the treatment response to DHEA and placebo

		RNA Content (%Change)				Protein Content (%Change)
	Intranuclear NF-κB (%Change)	p65	p105	TNFα	IL-1β	p65	IκB	Plasma TNFα (%Change)
Testosterone, ng/dl
r	0.613	0.128	0.354	0.243	0.661	0.613	−0.497	0.774
P	0.012*	0.637	0.179	0.364	0.005*	0.012*	0.049*	0.001*
Androstenedione, ng/dl
r	0.408	0.246	0.262	0.294	0.340	0.535	−0.390	0.614
P	0.117	0.358	0.327	0.269	0.198	0.033*	0.136	0.019*
DHEA-S, μg/dl
r	0.590	0.252	0.276	0.285	0.532	0.743	−0.413	0.682
P	0.016*	0.346	0.300	0.284	0.034	0.001*	0.112	0.007*

p65, NF-κB p65 subunit; p105, NF-κB p105 subunit; r, correlation coefficient; P, level of significance; DHEA-S, dehydroepiandrosterone sulfate.

^*P < 0.05.